Gimv Signs Agreement to Take Control of SpiraTec, an Automation Specialist with €90M in Revenue
According to the group, the transaction is part of its accelerated growth strategy: committing larger unit amounts to companies aiming for strong international expansion. The target designs, automates and modernises production lines for the pharmaceutical and chemical industries.
A Majority Stake Subject to Competition Clearance
Gimv, a European investment company listed on Euronext Brussels, announced on November 19, 2026 an agreement for the acquisition of a majority stake in SpiraTec AG. The transaction remains subject to the usual conditions, including approval from competition authorities, and its completion is expected before the end of the year.
The structure involves the management team in the share capital. Andreas Schadt and Frank Heines, founders and co-CEOs of SpiraTec, are making significant reinvestments and will remain at the head of the company. The shareholder and the management aim together to accelerate international development, through organic growth as well as acquisitions.
Founded in 2007 and based in Speyer, Germany, SpiraTec provides industrial automation, IT and engineering services to process industries. It operates across the entire value chain: consulting, planning, commissioning and validation, followed by maintenance and optimisation of sites already in operation.
Pharmaceuticals and chemicals constitute its main markets, with biotechnology also among the sectors served. The majority of projects concern the modernisation and optimisation of existing facilities, a positioning which, according to the press release, fosters lasting client relationships.
SpiraTec's business therefore depends on the investments that manufacturers devote to their production tools. The press release links its outlook to growing demand for secure, connected production incorporating artificial intelligence, as manufacturers invest in their long-term competitiveness.
More Than 650 Employees and Five Acquisitions Already Completed
SpiraTec generates revenue of approximately €90 million. The company employs more than 650 people, spread across more than 40 sites in Germany, France, Italy, Austria, Switzerland and the United States.
Its growth rests on two drivers. The press release reports strong organic growth, complemented by five acquisitions carried out in Germany, Italy and Switzerland. This development model based on successive acquisitions is expected to continue with the support of Gimv.
The plan also provides for accelerating expansion in Europe and the United States. The company already has locations on the American market: the objective therefore concerns extending an existing presence, rather than a first entry.
On the Gimv side, the investment is attached to the Smart Industries platform, dedicated to companies that combine industrial expertise with digital intelligence. For an investor committing its own balance sheet, the target presents a profile in which external growth holds a stated place in the roadmap, alongside the development of existing activities.
Investor and Founders Champion a Long-Term Vision
Ronald Bartel, partner at Gimv's Smart Industries platform, stated: “SpiraTec has built an impressive track record in nearly two decades and has become a trusted partner for some of the most demanding production environments in pharmaceuticals and chemicals.”
He added that the company's combined expertise in automation, IT and engineering “constitutes a solid foundation to continue its growth.” Gimv intends to support SpiraTec's next phase of development “both organically and through acquisitions.”
The founders stated: “With Gimv, we have found a partner that shares our long-term vision and has extensive experience in supporting companies in their international expansion and their external growth strategies.”